Colorectal cancer has emerged as the third most common cancer in Cyprus, with an alarming number of new cases diagnosed each year.
Andreas Evgeniou, President of the Gastroenterological Company of Cyprus, revealed that around 350 new patients are identified annually.
This concerning trend was addressed at a press conference jointly organised by the Gastroenterological Company, the Pancyprian Medical Association (PMA), and pharmaceutical company Medochemie, held in recognition of European Colorectal Cancer Month.
According to Evgeniou, while colorectal cancer primarily affects individuals over 60, recent studies in the United States show a worrying increase in its incidence among younger adults under 50.
He emphasised that prevention and early diagnosis remain the cornerstones in the fight against this disease.
Early detection saves lives
The emphasis lies on a two-pronged approach: empowering individuals to recognise symptoms and implementing regular colonoscopies for asymptomatic high-risk patients.
Evgeniou stressed the importance of public awareness campaigns to educate people about the warning signs.
Collaboration for better healthcare
Petros Agathangelou, President of the PMA, underscored the association’s commitment to collaborating with the Gastroenterological Company and Medochemie. He highlighted the importance of such initiatives in tackling colorectal cancer effectively.
Agathangelou further emphasised the need for equitable access to preventive and diagnostic services. He explained the PMA’s ongoing collaboration with relevant bodies to implement healthcare policies aimed at reducing colorectal cancer cases in Cyprus.
Raising awareness
Nicos Christodoulou, Sales Director of Medochemie, emphasised the company’s commitment to raising public awareness about this serious disease as part of its Corporate Social Responsibility programme.
He echoed Evgeniou’s message, urging people over 50 to consult their doctors about screening options for their digestive system, particularly the colon.
Risk factors and symptoms
The press conference acknowledged that the exact causes of colorectal cancer remain unclear. However, unhealthy dietary habits, family history, presence of polyps in the bowel, and chronic inflammation of the colon are identified as significant risk factors.
Common symptoms include rectal bleeding, anaemia, weight loss, appetite changes, weakness, fever, night sweats, abdominal pain, and altered bowel habits.
Colorectal cancer can sometimes be asymptomatic.
